Jun 26 |
Tempus wins FDA nod for AI-backed heart diagnostic
|
Jun 26 |
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib
|
Jun 26 |
This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan
|
Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Jun 19 |
IPO roundup: Lionheart Holdings, Melar Acquisition Corp. I, and more
|
Jun 14 |
Musk pay package, cruise line pressures: Market Domination
|
Jun 14 |
Tempus AI: Healthcare AI Play Faces Some Challenges From The Start
|
Jun 14 |
Tempus AI stock rises after Nasdaq debut via IPO
|
Jun 14 |
Tempus AI stock jumps 14% following $411M IPO
|
Jun 14 |
SoftBank-backed Tempus AI prices IPO at $37, valuing it above $6B
|